Skip to Main Content

Advertisement intended for health care professionals

Close

ASH
ASH Clinical News
ASH Image Bank Open External Link
ASH News Daily
ASH-SAP
Blood Journals
Hematology
The Hematologist
International

header search

search input Search input auto suggest

filter your search

Search

Menu

About
Viewpoints
Education
Spotlight
News
Topic Compilations

Skip Nav Destination

PDUFA Pending

A quick look at hematologic drugs pending approval by the U.S. Food and Drug Administration

Glofitamab Plus GemOx Combination ‘Completely Practice Changing’

May 28, 2025

ITP in Children Could Be Added Indication for Avatrombopag

May 28, 2025

Belantamab Mafodotin Best Used in Combination With Other Regimens

May 28, 2025

Linvoseltamab Looks to Join Armamentarium of Other Bispecifics for R/R MM

May 28, 2025

Odronextamab Back In Front of FDA for Approval

May 28, 2025

Approval Granted for New Acalabrutinib Indication

February 26, 2025

Fitusiran on the Horizon for Hemophilia

February 26, 2025

Advertisement intended for health care professionals

Connect with us:

CURRENT ISSUE
June 2025

Advertisement intended for health care professionals

About ASH Clinical News
Advertising
Subscribe

Contact Us
ASH Publications App

American Society of Hematology
2021 L Street NW, Suite 900
Washington, DC 20036
TEL +1 202-776-0544
FAX +1 202-776-0545

ASH Publications

Blood
Blood Advances
Blood Global Hematology
Blood Immunology & Cellular Therapy
Blood Neoplasia
Blood Red Cells & Iron
Blood Vessels, Thrombosis & Hemostasis
Hematology, ASH Education Program
ASH Clinical News
ASH-SAP
The Hematologist

American Society of Hematology

ASH Home
ASH Image Bank
ASH Store

Advocacy
Education
Meetings
Research

Copyright 2025 by American Society of Hematology

Cookie Settings
Privacy Policy
Cookie Policy
Terms of Use
Contact Us

This Feature Is Available To Subscribers Only

Sign In or Create an Account

Advertisement intended for health care professionals